Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Classical hematology 1

Conditions

Sarcoma 9Bone Neoplasms 3Neoplasms 2Breast Neoplasms 2Venous Thromboembolism 1Risk Reduction Behavior 1Rhabdomyosarcoma 1Prosthesis-Related Infections 1Osteosarcoma 1Neurofibrosarcoma 1Neuroendocrine Tumors 1Mesothelioma, Malignant 1Lymphoma 1Hematoma 1Gastrointestinal Stromal Tumors 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Neuroendocrine 1

Interventions

Enoxaparin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Hematoma × Sarcoma × Clear all
NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Massachusetts General Hospital

Phase 4 Enrolling by invitation
2,868 enrolled
Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡